Zomedica Corp.
ZOMDF
$0.11
-$0.01-4.97%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.69% | 13.59% | 3.80% | 7.61% | 10.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.69% | 13.59% | 3.80% | 7.61% | 10.24% |
| Cost of Revenue | 37.27% | 29.90% | -2.42% | 3.67% | -2.42% |
| Gross Profit | 7.43% | 6.97% | 7.04% | 9.36% | 16.00% |
| SG&A Expenses | -3.73% | -9.11% | -11.49% | -13.48% | 12.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83% | -1.15% | -8.61% | -14.26% | 17.42% |
| Operating Income | 11.21% | 11.15% | 16.09% | 28.35% | -25.08% |
| Income Before Tax | 8.69% | 69.32% | -584.82% | 66.21% | -178.89% |
| Income Tax Expenses | 29.63% | 108.39% | 65.66% | -148.15% | 98.59% |
| Earnings from Continuing Operations | 8.60% | 69.09% | -596.60% | 67.89% | -1,263.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.60% | 69.09% | -596.60% | 67.89% | -1,263.95% |
| EBIT | 11.21% | 11.15% | 16.09% | 28.35% | -25.08% |
| EBITDA | 13.05% | 13.47% | 23.11% | 35.81% | -24.36% |
| EPS Basic | 8.82% | 69.26% | -600.00% | 68.12% | -1,260.00% |
| Normalized Basic EPS | 7.14% | 7.84% | 15.00% | 28.79% | -44.83% |
| EPS Diluted | 8.82% | 69.26% | -600.00% | 27.07% | -1,260.00% |
| Normalized Diluted EPS | 7.14% | 7.84% | 15.00% | 28.79% | -44.83% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |